Brolucizumab Intravitreal Injections for Wet Age-Related Macular Degeneration: Real-Life Study on a Cohort of Italian Patients

<i>Background and Objectives:</i> To report the real-life Brolucizumab therapeutical outcomes of treatment-naïve and non-treatment-naïve eyes with neovascular age-related macular degeneration (nAMD) and to analyze the incidence of therapy-related adverse events. <i>Materials and Methods:</i> A total...

Celý popis

Podrobná bibliografie

Hlavní autoři:	Carlo Gesualdo, Settimio Rossi, Clemente Maria Iodice, Francesco Guarino, Mariachiara Petrella, Fabiana Anna D’Agostino, Raffaele Perrotta, Francesca Simonelli
Médium:	Artigo
Jazyk:	Inglês
Vydáno:	MDPI AG 2023-06-01
Edice:	Medicina
Témata:	age-related macular degeneration anti-vascular endothelial growth factor brolucizumab central retinal thickness exudation intravitreal injection
On-line přístup:	https://www.mdpi.com/1648-9144/59/6/1110
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!